By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Understanding and predicting bioavailability of subcutaneously (SC) administered biologics remains a key challenge in drug development. There is a need for reliable predictive models to improve formulation development and dose estimation for SC biologics.
Join Merck and Pion in this webinar as we explore the effectiveness and practical application of the Subcutaneous Injection Site Simulator (SCISSOR, Pion Inc.) - a promising in vitro model that aims to streamline the development of SC biologics.
Don't miss this opportunity! Reserve your place today to gain valuable insights.
.png){kind=icon}
